User:Elizabeth Perkins: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
|||
| Line 21: | Line 21: | ||
'''OHSU Main Hospital 8th Floor Conference Room 8B60''' | '''OHSU Main Hospital 8th Floor Conference Room 8B60''' | ||
*1/18/2011 - Brian Rubin,MD, PhD | *1/18/2011 - Brian Rubin,MD, PhD | ||
| Line 56: | Line 26: | ||
*2/15/2011 - John R. Ohlfest, PhD | *2/15/2011 - John R. Ohlfest, PhD | ||
*3/08/2011 - Amy Wagers,PhD | *3/08/2011 - Amy Wagers,PhD | ||
*3/29/2011 - William Stratford May, MD | *3/29/2011 - William Stratford May, MD | ||
*4/12/2011 - David Bentley, PhD | *4/12/2011 - David Bentley, PhD | ||
*6/14/2011 - James Ford,MD | *6/14/2011 - James Ford,MD | ||
Revision as of 10:58, 12 January 2011
Knight Cancer Institute Seminar Series
- Charles Keller, MD Pediatric Cancer Biology Program
- c/o Elizabeth Perkins, Administrative Coordinator
- Oregon Health & Science University
- Pape'Family Pediatric Research Institute
- Mail Code: L321
- 3181 SW Sam Jackson Park Road
- Portland, OR 97239
- 503-494-9962
- perkinel@ohsu.edu
http://portal.ohsu.edu/blogs/researchnews/
Objectives of the Knight Cancer Institute Seminar Series
The first annual Knight Cancer Institute Seminar series, co-sponsored by the Pediatric Cancer Biology program and the Knight Cancer Institute, will have a strong presence of childhood cancer basic and translational research topics presented by leading extramural scientists.
Knight Cancer Institute Seminar Series 2010-2011 Schedule
Tuesdays 4:00pm - 5:00pm
OHSU Main Hospital 8th Floor Conference Room 8B60
- 1/18/2011 - Brian Rubin,MD, PhD
"Mechanisms of Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor"
- 2/15/2011 - John R. Ohlfest, PhD
- 3/08/2011 - Amy Wagers,PhD
- 3/29/2011 - William Stratford May, MD
- 4/12/2011 - David Bentley, PhD
- 6/14/2011 - James Ford,MD
